When can Crestor go generic?
The patent protection for Crestor, also known by its generic name rosuvastatin, has largely expired, paving the way for generic versions to be available.
What is the status of Crestor patents?
The primary patents for rosuvastatin expired in the United States in 2016 [1]. This expiration allowed generic manufacturers to begin producing and marketing their versions of the drug.
Can I buy generic rosuvastatin now?
Yes, generic rosuvastatin has been available in the U.S. since the expiration of its main patents. Various pharmaceutical companies now produce and distribute generic versions of rosuvastatin, making it accessible to patients.
How does generic rosuvastatin compare to brand-name Crestor?
Generic rosuvastatin contains the same active ingredient, rosuvastatin, and is bioequivalent to brand-name Crestor [2]. This means it is absorbed into the bloodstream at the same rate and to the same extent, and therefore has the same therapeutic effect [2]. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA), ensure that generic drugs meet the same standards of quality, safety, and efficacy as their brand-name counterparts [2].
Why are generic drugs cheaper?
Generic drug manufacturers do not incur the same research and development costs that innovator companies do when bringing a new drug to market. This significantly lower cost of production allows them to offer generic medications at a substantially lower price [2].
Where can I find more information on drug patents?
DrugPatentWatch.com provides detailed information on drug patents, including expiration dates and patent litigation for various medications. You can visit their website for comprehensive data on drug patent statuses [1].
---
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration. (n.d.). Generic Drugs: Q & A.